About this trial

This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.

Eligibility criteria

Qualifiers

Patients (adults and children, all ages) initiating long-term parenteral nutrition

Followed at CHU de Bordeaux or Robert Debré Hospital (APHP)

Covered by French Social Security system

Written informed consent obtained from patient (if adult) or legal guardian (if minor)

Disqualifiers

Fitzpatrick skin type ≥ V (darker skin tones)

Forearm tattoos at the site of measurement

For patients included under 1 year of age: patients born prematurely (before 37 weeks of amenorrhea)

Pregnant or breastfeeding women.

Trial design

Treatments tested in this trial

  • Non-invasive skin AGE measurements

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

3
CHU de Bordeaux-Hôpital des enfants GH Pellegrin33076, Bordeaux France
AP-HP - Hopital Robert Debré75935, Paris France
CHU de Bordeaux - Hôpital Haut Lévêque33600, Pessac France

Sponsors and collaborators

University Hospital, Bordeaux

Lead sponsor